Cancer

Oncology bears a particular potential for translating research findings from the laboratory into clinical applications. Innovative strategies are urgently needed in the areas of diagnosis, patient risk stratification and treatment. The focus of the Division of Experimental Oncology of Ospedale San Raffaele is to develop translational research programs and clinical research. Any significant progress toward the cure of cancer can only be based on an improved understanding of its pathogenesis, which, in turn, will lead to the development of improved diagnostics and more rationale therapeutic interventions.

ORGANIZATION
The division is organized into 32 research units (10 basic research units and 22 clinical research units) with a total number of over 130 scientists including clinician-scientists. Extensive collaborations and joint activities will accelerate the implementation of translational research through access to a large number of patients and samples and combined resource platforms. 

The division is joining efforts with the Clinical Departments of Onco-hematology and Oncology to create a virtual cancer center with a network organization, multidisciplinary teams and defined programs for different tumors and takes advantage of the collaborative use of resources, platforms and infrastructures with other Research Divisions and facilities.

RESEARCH
Research performed in the Division of Experimental Oncology deals with three major topics:

  • cancer genetics;
  • cancer microenvironment;
  • cancer immunology and immunotherapy.

All three are addressed through a translational approach, thanks to the collaboration between the basic research units, the clinical research units and the hospital departments. 

More info can be found here.